Correlation Between Neurocrine Biosciences and Wave Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Wave Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Wave Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Wave Life Sciences, you can compare the effects of market volatilities on Neurocrine Biosciences and Wave Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Wave Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Wave Life.

Diversification Opportunities for Neurocrine Biosciences and Wave Life

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Neurocrine and Wave is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Wave Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Wave Life Sciences and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Wave Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Wave Life Sciences has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Wave Life go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Wave Life

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 4.25 times less return on investment than Wave Life. But when comparing it to its historical volatility, Neurocrine Biosciences is 3.48 times less risky than Wave Life. It trades about 0.07 of its potential returns per unit of risk. Wave Life Sciences is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  380.00  in Wave Life Sciences on September 19, 2024 and sell it today you would earn a total of  1,065  from holding Wave Life Sciences or generate 280.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Neurocrine Biosciences  vs.  Wave Life Sciences

 Performance 
       Timeline  
Neurocrine Biosciences 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.
Wave Life Sciences 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Wave Life Sciences are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Wave Life exhibited solid returns over the last few months and may actually be approaching a breakup point.

Neurocrine Biosciences and Wave Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurocrine Biosciences and Wave Life

The main advantage of trading using opposite Neurocrine Biosciences and Wave Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Wave Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wave Life will offset losses from the drop in Wave Life's long position.
The idea behind Neurocrine Biosciences and Wave Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio